Pro-Dex, Inc. (PDEX) vs Stereotaxis Inc. (STXS)

Pro-Dex, Inc. and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Pro-Dex, Inc. is the larger, with a market value of $195.8M against $105.2M — 1.9× the size. Stereotaxis Inc. has negative trailing earnings, so its P/E is not meaningful; Pro-Dex, Inc. trades at 16.4×. Pro-Dex, Inc. grew revenue faster over the last twelve months: 13.3% against −5.46%. Pro-Dex, Inc. has the higher net margin (15.1% vs −78.5%) and the higher return on invested capital (17.2% vs −203.6%). Across the 19 metrics below, Pro-Dex, Inc. leads on 17 and Stereotaxis Inc. on 2.

Valuation

Metric PDEX STXS Medical Instruments & Supplies median
P/E 16.42 n/m 30.28
P/S 2.48 3.46 2.49
P/B 4.00 8.50 2.34
Price to free cash flow 18.52 n/m 23.49
EV/EBITDA 13.20 n/m 14.87
EV/Sales 2.47 3.22 2.75
Earnings yield 6.09% (23.08%) 0.00%
Free cash flow yield 5.40% (14.90%) 0.59%

Profitability

Metric PDEX STXS Medical Instruments & Supplies median
Gross margin 32.45% 55.57% 53.60%
Operating margin 16.84% (75.68%) 1.97%
Net margin 15.12% (78.45%) 0.00%
Free cash flow margin 13.43% (51.56%) 2.36%
Return on equity 26.48% (344.36%) 0.00%
Return on assets 17.08% (48.76%) 0.00%
Return on invested capital 17.22% (203.58%) 0.13%

Growth

Metric PDEX STXS Medical Instruments & Supplies median
Revenue growth (TTM) 13.31% (5.46%) 8.97%
EPS growth (last fiscal year) 54.31% 16.67% 6.51%
Revenue growth, 5-year CAGR 15.32% 3.99% 8.85%
Net income growth, 5-year CAGR 17.23% 0.00% 0.00%

Health

Metric PDEX STXS Medical Instruments & Supplies median
Debt to equity 0.25 0.00 0.10
Current ratio 4.19 1.42 2.47
Net debt to EBITDA 0.27 0.65 0.97

Dividend

Metric PDEX STXS Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric PDEX STXS Medical Instruments & Supplies median
Market cap 195.84m 105.21m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack